NCT06755034

Brief Summary

The investigators are evaluating the use of a single implant to stabilize complete dentures in the lower jaw, in the canine region of the preferred chewing side. They are conducting this study to determine whether this treatment concept gives satisfactory results, and how it compares with the standard position in the center of the lower jaw.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
68mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jan 2025Dec 2031

First Submitted

Initial submission to the registry

December 15, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 1, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2031

Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

6.9 years

First QC Date

December 15, 2024

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • OHIP-EDENT

    Oral health-related quality of life questionnaire

    From baseline to 5-year follow-up

  • DSI

    Denture Satisfaction Index (questionnaire)

    From baseline to 5-year follow-up

Secondary Outcomes (9)

  • Preferred chewing side

    From baseline to 5-year follow-up

  • Chewing efficiency

    From baseline to 5-year follow-up

  • Occlusal analysis

    From baseline to 5-year follow-up

  • Plaque index

    From implant loading to 5-year follow-up

  • Bleeding on probing

    From implant loading to 5-year follow-up

  • +4 more secondary outcomes

Study Arms (2)

c-SIMO

EXPERIMENTAL

Placement of an implant in the mandibular canine area and using it to stabilize a pre-existing mandibular complete denture.

Device: c-SIMO

m-SIMO

ACTIVE COMPARATOR

Placement of an implant in the midline of the mandible and using it to stabilize a pre-existing mandibular complete denture.

Device: m-SIMO

Interventions

c-SIMODEVICE

Placement of an implant in the mandibular canine area and using it to stabilize a pre-existing mandibular complete denture.

c-SIMO
m-SIMODEVICE

Placement of an implant in the midline of the mandible and using it to stabilize a pre-existing mandibular complete denture.

m-SIMO

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent signed by the subject
  • Age ≥ 60 years
  • Edentulous and wearing sufficient complete maxillary and mandibular dentures or ones that can be rendered sufficient via a reline and/or renewal of the prosthetic teeth
  • Healed edentulous mandible (minimum 6-8 weeks since last extraction in the anterior zone (4-4) and one year in the posterior zone (5-8))
  • Physical status ASA1 and ASA2

You may not qualify if:

  • Contraindications to the medical devices used, e.g. known hypersensitivity or allergy
  • Vulnerable subjects
  • Enrollment of the investigator, his/her family members, employees and other dependent persons
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to perform adequate oral hygiene
  • Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, Parkinson etc. of the subject (Dementia: clock-drawing test score ≤ 5)
  • Surgical risk factors such as, but not limited to, uncontrolled diabetes, immunosuppression, radiation, chemotherapy, or antiresorptive medication (ex. Bisphosphonates)
  • Heavy smoking habit: \>20 cig/d
  • Reported severe bruxism or clenching habits, clinically present oro-facial pain
  • Depression: Geriatric Depression Scale \> 9
  • Xerostomia: SSFR ≤ 0.7ml/min
  • Ridge dimensions \<6 mm (width) by 10 mm (height) in the canine or midline area
  • Ridge defects requiring bone augmentation procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinics of Dental Medicine, University of Geneva

Geneva, Canton of Geneva, 1211, Switzerland

RECRUITING

Study Officials

  • Sabrina Maniewicz

    University of Geneva

    PRINCIPAL INVESTIGATOR
  • Frauke Müller

    University of Geneva

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, Head of Division

Study Record Dates

First Submitted

December 15, 2024

First Posted

January 1, 2025

Study Start

January 1, 2025

Primary Completion (Estimated)

December 1, 2031

Study Completion (Estimated)

December 1, 2031

Last Updated

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations